References

1. Barnes, D.J.; Melo, J.V. Cytogenetic and molecular genetic aspects of chronic myeloid leukemia. Acta Haematol. 2002, 108, 180-202.

2. Johansson, B.; Fioretos, T.; Mitelman, F. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol. 2002, 107, 76-94.

3. Shepter, P.J.; Ben-Yehuda, D. Molecular evolution of chronic myeloid leukaemia. Semin. Cancer Biol. 2001, 11, 313-322.

4. Huntly, B.J.; Bench, A.; Green, A.R. Double jeopardy from a single translocation: Deletions of the derivative chromosome 9 in chronic myeloid leukemia. Blood 2003, 102 (4), 1160-1168.

5. O'Dwyer, M.E.; Mauro, M.J.; Druker, B.J. Recent advancements in the treatment of chronic myelogenous leukemia. Annu. Rev. Med. 2002, 53, 369-381.

6. Kantarjian, H.M.; O'Brien, S.; Cortes, J.E.; Shan, J.; Giles, F.J.; Rios, M.B.; Faderl, S.H.; Wierda, W.G.; Ferrajoli, A.; Verstovsek, S.; Keating, M.J.; Freireich, E.J.; Talpaz, M. Complete cytogenetic and molecular responses to interfer-on-a-based therapy for chronic myelogenous leukemia are associated with excellent long-term prognosis. Cancer 2003, 97, 1033-1041.

7. Kantarjian, H.M.; Talpaz, M.; Cortes, J.; O'Brien, S.; Faderl, S.; Thomas, D.; Giles, F.; Rios, M.B.; Shan, J.; Arlinghaus, R. Quantitative polymerase chain reaction monitoring of BCR-ABL during therapy with imatinib mesylate (STI571; Gleevec) in chronic-phase chronic myelogenous leukemia. Clin. Cancer Res. 2003,9,160-166.

8. O'Brien, S.G.; Guilhot, F.; Larson, R.A.; Gathmann, I. Baccarani, M.; Cervantes, F.; Cornelissen, J.J.; Fischer T.; Hochhaus, A.; Hughes, T.; Lechner, K.; Nielsen, J.L. Rousselot, P.; Reiffers, J.; Saglio, G.; Shepherd, J. Simonsson, B.; Gratwohl, A.; Goldman, J.M.; Kantarjian H.; Taylor, K.; Verhoef, G.; Bolton, A.E.; Capdeville, R. Druker, B.J. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N. Engl. J. Med. 2003, 348, 994-1004.

9. Branford, S.; Rudzki, Z.; Harper, A.; Grigg, A.; Taylor, K.; Durrant, S.; Arthur, C.; Browett, P.; Schwarer, A.P.; Ma, D.; Seymour, J.F.; Bradstock, K.; Joske, D.; Lynch, K.; Gathmann, I.; Hughes, T.P. Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Leukemia 2003, 17, 2401-2409.

10. Hughes, T.P.; Kaeda, J.; Branford, S.; Rudzki, Z.; Hochhaus, A.; Hensley, M.L.; Gathmann, I.; Bolton, A.E.; van Hoomissen, I.C.; Goldman, J.M.; Radich, J.P. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia. N. Engl. J. Med. 2003, 349, 1423-1432.

11. Nardi, V.; Azam, M.; Daley, G.Q. Mechanisms and implications of imatinib resistance mutations in BCR-ABL. Curr. Opin. Hematol. 2004, 11, 35-43.

12. Hochhaus, A. Detection and Quantification of Leukemia-Specific Rearrangements. In Methods in Molecular Medicine; Boultwood, J., Fidler, C., Eds.; Humana Press: Totowa, NJ, 2002; Vol. 68, 67-96.

13. Biernaux, C.; Loos, M.; Sels, A.; Huez, G.; Stryckmans, P. Detection of major bcr-abl gene expression at a very low level in cells of some healthy individuals. Blood 1995, 86 (8), 3118-3122.

14. Radich, J.P.; Gehley, G.; Gooley, T.; Bryant, E.; Clift, R.A.; Collins, S.; Edmands, S.; Kirk, J.; Lee, A.; Kessler, P.; Schoch, G.; Buckner, C.D.; Sullivan, K.M.; Applebaum, F.R.; Thomas, E.D. Polymerase chain reaction detection of the BCR-ABL fusion transcript after alloge-neic marrow transplantation for chronic myeloid leukemia: Results and implications in 346 patients. Blood 1995, 85, 2632-2638.

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment